pyrazines has been researched along with Atheroma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandl, R; Busygina, K; Deckmyn, H; Jamasbi, J; Lorenz, R; Seiler, T; Siess, W; Weber, C | 1 |
Jiang, S; Jin, F; Li, K; Ma, S; Yang, D; Yang, Y; Zhang, X; Zhang, Y | 1 |
Chen, DM; Shi, CG; Sun, MZ; Wang, GF; Wang, HF; Wang, L; Wu, SX; Xu, ZQ | 1 |
3 other study(ies) available for pyrazines and Atheroma
Article | Year |
---|---|
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.
Topics: Adenine; Administration, Oral; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Benzamides; Humans; Imidazoles; Male; Middle Aged; Piperidines; Plaque, Atherosclerotic; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Pyrazines; Pyrazoles; Pyrimidines; Thrombosis | 2018 |
Acipimox attenuates atherosclerosis and enhances plaque stability in ApoE-deficient mice fed a palmitate-rich diet.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Diet, Atherogenic; Hypolipidemic Agents; Male; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Mutant Strains; Palmitates; Plaque, Atherosclerotic; Pyrazines; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2012 |
Tetramethylpyrazine attenuates atherosclerosis development and protects endothelial cells from ox-LDL.
Topics: Animals; Aorta, Abdominal; Atherosclerosis; Cell Adhesion; Cell Culture Techniques; Cell Movement; Cells, Cultured; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Endothelial Cells; Immunohistochemistry; Ligusticum; Lipoproteins, LDL; Male; Plaque, Atherosclerotic; Pyrazines; Rabbits; Rats; Rats, Sprague-Dawley; Triglycerides | 2013 |